Medicare has announced it will pay for Provenge ( sipuleucel-T ) to treat metastatic prostate cancer. This drug extends the life of patients by about four months.

Sexual activities are obviously quite different between homosexual and heterosexual men. A research study shows they also have different responses to the same hormone adjusting drug.

Life with advanced prostate cancer is measured in months, usually. The U.S. Food and Drug Administration (FDA) has recently approved a new medicine that offers men the gift of time.

Smoking and lung cancer are known links. Now it's becoming clear that tobacco addiction significantly complicates the outlook for men diagnosed with prostate cancer.

Certain hormones can make prostate cancer worse. One treatment for this type of cancer is to stop these hormones from being made. However, that treatment can put men at risk for diabetes.

Terror, panic and worries raises blood pressure. And that's just what the millions of people in this country living with high blood pressure felt last year. Today, they can take a long sigh. 

There's been a lot of controversy about what rising PSA (prostate-specific antigen) levels actually mean. A new study answers some of these concerns. Men whose PSA levels continue to be elevated over a period of years are more likely to develop prostate cancer.

The standard test for prostate cancer has been around for 30 years. A new test is being developed that screens for more than PSA to pinpoint the cancer more reliably.

Brisk walking is a good aerobic activity for anyone. It's now known to be particularly healthful for newly diagnosed prostate cancer patients.

A new class of cancer fighting drugs that seems to hold promise in treating breast cancer may also work with certain types of prostate cancer. Those are the findings of a new University of Michigan (U-M) study.